The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Study of patient risk factors for febrile neutropenia in non-Hodgkin lymphoma receiving R-CHOP regimen: STOP FN single institution analysis in Japan.
 
Masahiro Yokoyama
Consulting or Advisory Role - Chugai Pharma
 
Yoshiharu Kusano
No Relationships to Disclose
 
Anna Takahashi
No Relationships to Disclose
 
Norihito Inoue
No Relationships to Disclose
 
Tadahiro Gunji
No Relationships to Disclose
 
Hideaki Nitta
No Relationships to Disclose
 
Kyoko Ueda
No Relationships to Disclose
 
Noriko Nishimura
Consulting or Advisory Role - Chugai Pharma
 
Yuko Mishima
Consulting or Advisory Role - Chugai Pharma
 
Yasuhito Terui
No Relationships to Disclose
 
Kiyohiko Hatake
Speakers' Bureau - Kyowa Hakko Kirin; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Abbvie; Bayer; Celgene; Chugai Pharma; GlaxoSmithKline; Janssen; Ono Pharmaceutical; Takeda